Fidelity Management & Research (FMR) Portfolio
Fidelity Management & Research (FMR) is managed by Abigail Johnson; 13F filer (CIK 0000315066).
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Abigail Johnson — tracked via quarterly SEC 13F filings · All famous investors
Q3 2026 · 5518 positions · Total reported value $2,182.74B · Top-10 concentration 38.4% · Updated 2026-11-13
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
Turnover: 46.9% · 430 new · 2012 cut · 273 exited
Active Share (vs S&P 500): 36.1% · vs QQQ: 51.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -0.9% · vs SPY -3.0% · Prev Value $2,228.17B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -3.1% · vs SPY -5.2% · Latest Value $2,182.74B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2026 13F filing, Fidelity Management & Research (FMR) disclosed 5518 equity positions with a combined reported value of $2.18T. The filing implies a moderately concentrated portfolio: its ten largest positions account for 38.4% of reported value. HoldingsHub classifies the profile as Mega / Technology Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were NVDA ($213.03B), AAPL ($123.21B), MSFT ($104.52B). By sector, the heaviest allocations are Technology 47.6%, Consumer Discretionary 11.9%. Versus the prior quarter, allocation shifted toward Technology (+2.9pp), Health Care (+1.2pp) and away from Information Technology (-0.5pp), Energy (-0.7pp).
Versus the prior quarter, Fidelity Management & Research (FMR) opened 430 new positions, trimmed 2012 and fully exited 273, a turnover rate of 46.9% of positions. The portfolio's overlap with the prior quarter was 88% of names.
The largest new positions opened in Q3 2026 were SKHY ($1.33B), LIME ($224.76M), ADIG ($197.11M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
- SKHY SK HYNIX INC · $1.33B
- LIME NEUTRON HOLDINGS INC · $224.76M
- ADIG ADI GLOBAL DISTR INC · $197.11M
- CGSD CAPITAL GROUP · $147.89M
- BSP BENDING SPOONS SPA · $127.12M
- MFP MIDERA FOOD PROCESSING INC · $109.88M
- ANIX ANIXA BIOSCIENCES · $102.44M
- UROY URANIUM RTY CORP · $62.19M
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest Abigail Johnson buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-11-10 | Sell | Avalyn Pharma Inc. | 47,889 | $30.28 | SEC filing |
| 2026-11-10 | Sell | Avalyn Pharma Inc. | 5,565 | $29.56 | SEC filing |
| 2026-11-09 | Sell | Avalyn Pharma Inc. | 1,339 | $29.75 | SEC filing |
| 2026-11-09 | Sell | Avalyn Pharma Inc. | 173,661 | $29.06 | SEC filing |
| 2026-06-26 | Sell | Beam Therapeutics Inc. | 251,488 | $35.26 | SEC filing |
| 2026-06-25 | Sell | Beam Therapeutics Inc. | 33,372 | $35.12 | SEC filing |
| 2026-05-01 | Conversion | Avalyn Pharma Inc. | 377,948 | — | SEC filing |
| 2026-05-01 | Conversion | Avalyn Pharma Inc. | 225,843 | — | SEC filing |
Fund Profile
Fidelity Management & Research (FMR) is an SEC-registered 13F filer. As of Q2 2026 it reported 5,361 US equity positions with a combined value of $2.23T. HoldingsHub carries 20 quarters of its filings (Q3 2021–Q2 2026).
Portfolio Structure
- 5,361 positions · $2.23T reported value (Q2 2026)
- Top 10 holdings = 35.1% of reported value
- Largest position: NVDA (NVIDIA CORPORATION) at 9.2%
- Average position size: $415.63M
Sector Tilt
- Information Technology 47.2%
- Consumer Discretionary 12.7%
- Health Care 8.5%
- (classified holdings cover 94% of value)
Quarterly Activity
- Q2 2026: 349 new, 2800 added, 1771 reduced, 207 exited
- 441 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
932.81M | $213.03B | 9.76% | Reduce | |
| 2 |
|
369.99M | $123.21B | 5.64% | Add | |
| 3 |
|
203.78M | $104.52B | 4.79% | Add | |
| 4 |
|
247.67M | $85.22B | 3.90% | Reduce | |
| 5 |
|
322.64M | $80.39B | 3.68% | Reduce | |
| 6 |
|
101.42M | $73.55B | 3.37% | Add | |
| 7 |
|
127.43M | $44.75B | 2.05% | Reduce | |
| 8 |
|
116.88M | $39.83B | 1.82% | Reduce | |
| 9 |
|
35.49M | $37.81B | 1.73% | Add | |
| 10 |
|
248.29M | $36.33B | 1.66% | Reduce | |
| 11 |
|
29.96M | $34.67B | 1.59% | Add | |
| 12 |
|
53.29M | $32.60B | 1.49% | Add | |
| 13 |
|
65.37M | $29.82B | 1.37% | Add | |
| 14 |
|
47.95M | $17.23B | 0.79% | Add | |
| 15 |
|
22.17M | $14.97B | 0.69% | Add | |
| 16 |
|
31.57M | $14.35B | 0.66% | Add | |
| 17 |
|
38.82M | $13.77B | 0.63% | Reduce | |
| 18 |
|
7.80M | $13.57B | 0.62% | Reduce | |
| 19 |
|
23.87M | $13.16B | 0.60% | Hold | |
| 20 |
|
31.87M | $12.66B | 0.58% | Add | |
| 21 |
|
101.07M | $12.15B | 0.56% | Add | |
| 22 |
|
31.06M | $11.40B | 0.52% | Add | |
| 23 |
|
58.96M | $11.35B | 0.52% | Add | |
| 24 |
|
5.98M | $10.84B | 0.50% | Add | |
| 25 |
|
58.16M | $10.82B | 0.50% | Reduce | |
| 26 |
|
40.14M | $10.63B | 0.49% | Add | |
| 27 |
|
55.54M | $10.60B | 0.49% | Add | |
| 28 |
|
11.47M | $10.58B | 0.48% | Add | |
| 29 |
|
125.45M | $10.58B | 0.48% | Add | |
| 30 |
|
31.99M | $10.51B | 0.48% | Reduce | |
| 31 |
|
39.42M | $10.42B | 0.48% | Reduce | |
| 32 |
|
221.17M | $9.24B | 0.42% | Add | |
| 33 |
|
48.98M | $9.16B | 0.42% | Add | |
| 34 |
|
44.61M | $9.08B | 0.42% | Reduce | |
| 35 |
|
102.78M | $8.85B | 0.41% | Reduce | |
| 36 |
|
58.27M | $8.68B | 0.40% | Reduce | |
| 37 |
|
38.71M | $8.58B | 0.39% | Add | |
| 38 |
|
25.36M | $8.39B | 0.38% | Reduce | |
| 39 |
|
85.32M | $8.11B | 0.37% | Reduce | |
| 40 |
|
38.90M | $7.58B | 0.35% | Reduce | |
| 41 |
|
40.91M | $7.54B | 0.34% | Add | |
| 42 |
|
50.43M | $7.48B | 0.34% | Add | |
| 43 |
|
46.22M | $6.72B | 0.31% | Add | |
| 44 |
|
49.98M | $6.54B | 0.30% | Hold | |
| 45 |
|
17.77M | $6.25B | 0.29% | Reduce | |
| 46 |
|
9.26M | $6.22B | 0.28% | Add | |
| 47 |
|
21.48M | $6.17B | 0.28% | Hold | |
| 48 |
|
21.47M | $6.11B | 0.28% | Add | |
| 49 |
|
4.45M | $6.00B | 0.28% | Reduce | |
| 50 |
|
13.68M | $5.65B | 0.26% | Add | |
FAQ
What did Fidelity Management & Research (FMR) buy in 2026-Q3?
In its 2026-Q3 13F filing, Fidelity Management & Research (FMR) reported 5518 equity positions worth $2.18T in aggregate; its largest disclosed positions were NVDA ($213.03B), AAPL ($123.21B), MSFT ($104.52B).
How large is Fidelity Management & Research (FMR)'s portfolio?
Fidelity Management & Research (FMR) reported $2.18T of long equity holdings across 5518 positions as of 2026-Q3. Top-10 holdings account for 38.4% of reported value.
What is Fidelity Management & Research (FMR)'s investment style?
HoldingsHub classifies the portfolio as Mega / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.